Molecular Imaging using amino-acid PET tracer: Clinical research for diagnostic and therapeutic evaluation with amino acid PET tracer for multiple myeloma
Not Applicable
- Conditions
- Multiple myeloma
- Registration Number
- JPRN-UMIN000024072
- Lead Sponsor
- athional Center for Global Health and Medicine. Division of Nuclear Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 125
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patient in emargency state 2)Uncontorolable diabetics 3)Patient with severe comorbid disease includng liver dysfunction, renel failure or metabolic damage. 4)Patient with psychiatric disease 5)pregnant female, possible pregnant female, breast-feeding woman 6) allergy for Methionine 7) Those who are determined as not appropriate for the study by the principle investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To explore how Methionin PET/CT can contribute to initial diagnosis, treatment plannning and therapeutic effect of multiple myeloma.
- Secondary Outcome Measures
Name Time Method